A CEO of the Cell Technology and DNA Drugs Laboratory and Associate Professor of the Department of Biochemistry of the Crimean Federal University (CFU) Vladimir Oberemok told that specialists and scientists of the V.I. Vernadsky Crimean Federal University had developed a new anti-coronavirus vaccine.
“Our original vaccine is consisted of one of lasso-shaped oligonucleotides (thiophosphated DNA fragments), which contains both an inner immune system’s activator formed in CpG islands and antigen integrated with a small piece of the SARS-CoV-2 genome. That will help a human body to identify the antigen and produce required specific antibodies. After a patient is vaccinated, it is expected a person will never face with a real threat of infection. The solidity of the vaccine’s effect is achieved with the assistance of properties of thiophosphated oligonucleotides, which penetrate into human cells and possess a prolonged effect”, — the Press Service of CFU quoted the scientist’s words.
The main peculiarity of that new drug is a method of taking it.
“Another one advantage of our vaccine is an intranasal way of taking the medicine. To cut a long story short, it means you just inhale the Crimean anti-coronavirus drug and don’t need to make an injection at all”, — Vladimir Oberemok noticed.
The professor also added that anti-COVID-19 vaccines must be developed only in competitive conditions. Thanks to that, scientists will get an opportunity to find and create effective examples of remedies. Specialists are ready to initiate all the phases of a vaccine testing right after getting required financial assets.
Reference: KIA
